Debevoise & Plimpton LLP
Client SatisfactionPredominantly working out of the New York office, Debevoise & Plimpton LLP‘s team is noted for its focus on private equity transactions within the healthcare and life sciences spaces. The group regularly advises on equity and debt financing arrangements, and class actions concerning overbilling practices. Key names within the team include corporate and M&A expert Andrew Bab, and Paul Rubin, who leads the FDA regulatory team from Washington DC. Mark Goodman and Maura Monaghan are noted for their expertise in commercial litigation, with Goodman standing out for his experience in handling white-collar crime matters and government investigations. Kevin Rinker and Jennifer Chu are both known for their expansive knowledge of M&A and private equity buyouts within the healthcare and life sciences sectors.
Key clients
- agilon
- Carlyle
- Former directors and shareholders of Purdue Pharma, Inc.
- Clayton, Dubilier & Rice, LLC
- Deutsche Bank
- EmblemHealth
- Gedeon Richter
- Gentiva
- GlaxoSmithKline
- Hospital Corporation of America and subsidiaries
- J.P. Morgan Securities
- JAB Holdings
- Merck KGaA
- Resonetics
- StanCorp Financial
- SVB Leerink
- TPG Capital
Work highlights
- Advising Gentiva, a portfolio company of Clayton, Dubilier & Rice, on its acquisition of the Heartland hospice and home care business of ProMedica, which has an estimated value of $710m.
- Representing former directors and shareholders of Purdue Pharma, Inc., in litigation regarding prescription opioids, including a federal multi-district litigation and actions brought by state attorneys general, and in efforts to negotiate a global settlement in bankruptcy court.
- Advising TPG Growth on the acquisition of a majority stake in Crowe Healthcare Consulting, establishing the business as an independent entity to be rebranded as Kodiak Solutions.
Practice head
The lawyer(s) leading their teams.
Andrew Bab, Jennifer Chu, Mark Goodman, Maura Monaghan, Kevin Rinker, Paul Rubin